BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32565090)

  • 1. Electrolyte Abnormalities in Patients Presenting With Ventricular Arrhythmia (from the LYTE-VT Study).
    Laslett DB; Cooper JM; Greenberg RM; Yesenosky GA; Basil A; Gangireddy C; Whitman IR
    Am J Cardiol; 2020 Aug; 129():36-41. PubMed ID: 32565090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potassium Disturbances and Risk of Ventricular Fibrillation Among Patients With ST-Segment-Elevation Myocardial Infarction.
    Ravn Jacobsen M; Jabbari R; Glinge C; Kjær Stampe N; Butt JH; Blanche P; Lønborg J; Wendelboe Nielsen O; Køber L; Torp-Pedersen C; Pedersen F; Tfelt-Hansen J; Engstrøm T
    J Am Heart Assoc; 2020 Feb; 9(4):e014160. PubMed ID: 32067598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypomagnesemia and concurrent acid-base and electrolyte abnormalities in patients with congestive heart failure.
    Milionis HJ; Alexandrides GE; Liberopoulos EN; Bairaktari ET; Goudevenos J; Elisaf MS
    Eur J Heart Fail; 2002 Mar; 4(2):167-73. PubMed ID: 11959045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of spironolactone on ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators.
    Zarraga IG; Dougherty CM; MacMurdy KS; Raitt MH
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):739-47. PubMed ID: 22773022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiazide but not loop diuretics is associated with hypomagnesaemia in the general population.
    Kieboom BCT; Zietse R; Ikram MA; Hoorn EJ; Stricker BH
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1166-1173. PubMed ID: 30095199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Lethal Arrhythmic Events Through Remote Monitoring Using Heart Rate Variability Analysis in Patients with an Implantable Cardioverter Defibrillator.
    Shirakawa Y; Niwano S; Oikawa J; Saito D; Sato T; Matsuura G; Arakawa Y; Kobayashi S; Nishinarita R; Horiguchi A; Ishizue N; Kishihara J; Fukaya H; Ako J
    Int Heart J; 2020 Sep; 61(5):927-935. PubMed ID: 32879263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of serum potassium-influencing antihypertensive drugs on the risk of out-of-hospital cardiac arrest: A case-control study.
    Alharbi FF; Souverein PC; de Groot MCH; Blom MT; de Boer A; Klungel OH; Tan HL
    Br J Clin Pharmacol; 2017 Nov; 83(11):2541-2548. PubMed ID: 28662543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development and validation of a clinical predictive model for the risk of malignant ventricular arrhythmia during hospitalization in patients with acute myocardial infarction].
    Sun L; Mao L; Zou A; Chi B; Chen X; Ji Y; Jiang J; Zhou X; Wang Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Apr; 33(4):438-442. PubMed ID: 34053487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory biomarkers are not predictive of intermediate-term risk of ventricular tachyarrhythmias in stable CHF patients.
    Konstantino Y; Kusniec J; Reshef T; David-Zadeh O; Mazur A; Strasberg B; Battler A; Haim M
    Clin Cardiol; 2007 Aug; 30(8):408-13. PubMed ID: 17680622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction.
    Pride YB; Appelbaum E; Lord EE; Sloan S; Cannon CP; Sabatine MS; Gibson CM;
    Am J Cardiol; 2009 Aug; 104(4):475-9. PubMed ID: 19660597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes.
    Piccini JP; White JA; Mehta RH; Lokhnygina Y; Al-Khatib SM; Tricoci P; Pollack CV; Montalescot G; Van de Werf F; Gibson CM; Giugliano RP; Califf RM; Harrington RA; Newby LK
    Circulation; 2012 Jul; 126(1):41-9. PubMed ID: 22645292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
    Klein G; Lissel C; Fuchs AC; Gardiwal A; Oswald H; Desousa M; Pichlmaier AM; Lichtinghagen R; Geerlings H; Lippolt P; Niehaus M; Drexler H; Korte T
    Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis.
    Brisco-Bacik MA; Ter Maaten JM; Houser SR; Vedage NA; Rao V; Ahmad T; Wilson FP; Testani JM
    J Am Heart Assoc; 2018 Sep; 7(18):e009149. PubMed ID: 30371181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention.
    Mehta RH; Starr AZ; Lopes RD; Hochman JS; Widimsky P; Pieper KS; Armstrong PW; Granger CB;
    JAMA; 2009 May; 301(17):1779-89. PubMed ID: 19417195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and long-term prognosis in patients with chronic heart failure and reduced ejection fraction in China.
    Liu X; Yu H; Pei J; Chu J; Pu J; Zhang S
    Heart Lung Circ; 2014 Sep; 23(9):818-26. PubMed ID: 24881031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and prognosis of ventricular tachycardia/ventricular fibrillation in patients with post-infarction left ventricular aneurysm: Analysis of 575 cases.
    Ning X; Ye X; Si Y; Yang Z; Zhao Y; Sun Q; Chen R; Tang M; Chen K; Zhang X; Zhang S
    J Electrocardiol; 2018; 51(4):742-746. PubMed ID: 29803411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk stratification for complex ventricular arrhythmia complicating ST-segment elevation myocardial infarction.
    Podolecki TS; Lenarczyk RK; Kowalczyk JP; Jedrzejczyk-Patej EK; Chodor PK; Mazurek MH; Francuz PJ; Streb WA; Mitrega KA; Kalarus ZF
    Coron Artery Dis; 2018 Dec; 29(8):681-686. PubMed ID: 30234552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma potassium, serum magnesium and ventricular fibrillation: a prospective study.
    Higham PD; Adams PC; Murray A; Campbell RW
    Q J Med; 1993 Sep; 86(9):609-17. PubMed ID: 8255976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.